Development of iPSC-Derived Gamma Delta T Cell Therapies for Treatment of Liquid & Solid Tumors
Time: 3:30 pm
day: Day Two
Details:
- Harnessing the power of induced pluripotent stem cells (iPSCs) to develop novel allogeneic CAR-T cell therapies for cancer
- Multiplex engineering of iPSCs to develop allogeneic Gamma Delta T cells that can safely and effectively mediate anti-tumor immunity
- CAR design strategies that address disease-specific challenges
